Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer

scientific article

Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1148/RADIOL.2351040248
P698PubMed publication ID15703313

P50authorTae Hyun KimQ44335337
P2093author name stringJoo Young Kim
Sung Yong Park
Kwan Ho Cho
Jin Soo Lee
Dae Ho Lee
Dae Yong Kim
Kyung Hwan Shin
Jae Ill Zo
Jong Mog Lee
Bin Hwangbo
Hyae Young Kim
Hong Ryull Pyo
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectlung cancerQ47912
adaptive radiation therapyQ180507
P304page(s)208-215
P577publication date2005-02-09
P1433published inRadiologyQ3285690
P1476titleDose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer
P478volume235

Reverse relations

cites work (P2860)
Q36569090A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis
Q35854707A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy
Q33645619Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy
Q41712007Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton and 3D Conformal Radiotherapy (3D-CRT) for Reducing Perioperative Cardiopulmonary Complications in Esophageal Cancer Patients
Q33907268Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy
Q37705404Analysis of predictive factors for lung injury after forward-planned intensity-modulated radiotherapy in whole breast irradiation.
Q82776276Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy
Q36234757Association between absolute volumes of lung spared from low-dose irradiation and radiation-induced lung injury after intensity-modulated radiotherapy in lung cancer: a retrospective analysis
Q26795474Breathing guidance in radiation oncology and radiology: A systematic review of patient and healthy volunteer studies
Q83292332Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial
Q36343856Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours
Q57116818Comparison of treatment plan quality of VMAT for esophageal carcinoma with: flattening filter beam versus flattening filter free beam
Q36310203Correlation of conventional and conformal plan parameters for predicting radiation pneumonitis in patients treated with breast cancer
Q33820556Differences in irradiated lung gene transcription between fibrosis-prone C57BL/6NHsd and fibrosis-resistant C3H/HeNHsd mice
Q41378289Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy
Q36724932Dosimetric evaluation of a simple planning method for improving intensity-modulated radiotherapy for stage III lung cancer
Q33779707Dosimetric factors and Lyman normal-tissue complication modelling analysis for predicting radiation-induced lung injury in postoperative breast cancer radiotherapy: a prospective study
Q33637920Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning
Q44955795Effectiveness of 125I seed implantation in the treatment of non-small cell lung cancer during R2 resection
Q57040927Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients
Q42284346Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis
Q36230969Functional dose-volume histograms for predicting radiation pneumonitis in locally advanced non-small cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy
Q36451560Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy
Q38038330ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context
Q86065211Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapy
Q89622467Left Ventricular Systolic Dysfunction Is a Possible Independent Risk Factor of Radiation Pneumonitis in Locally Advanced Lung Cancer Patients
Q45060689Lung and Heart Dose Variability During Radiation Therapy of Non-Small Cell Lung Cancer.
Q38610456Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades
Q41067553Moderate hypofractionated image-guided thoracic radiotherapy for locally advanced node-positive non-small cell lung cancer patients with very limited lung function: a case report
Q43866769On the use of published radiobiological parameters and the evaluation of NTCP models regarding lung pneumonitis in clinical breast radiotherapy
Q87181760Postoperative chemoradiotherapy following pancreaticoduodenectomy. Impact of dose-volumetric parameters on the development of diabetes mellitus
Q90012768Precise prediction of the radiation pneumonitis in lung cancer: an explorative preliminary mathematical model using genotype information
Q34298368Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis
Q34355784Prediction of radiation pneumonitis in lung cancer patients: a systematic review.
Q54334825Predictive factors for radiation pneumonitis in lung cancer treated with helical tomotherapy.
Q46014428Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy.
Q36786779Predictors of radiation pneumonitis and pulmonary function changes after concurrent chemoradiotherapy of non-small cell lung cancer.
Q39426003Pulmonary toxicity generated from radiotherapeutic treatment of thoracic malignancies
Q37695563Radiation dose-volume effects in the lung.
Q33271980Retrospective monte carlo dose calculations with limited beam weight information
Q33782351Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: a retrospective clinical study
Q36318005Single-nucleotide polymorphisms of TGFβ1 and ATM associated with radiation-induced pneumonitis: a prospective cohort study of thoracic cancer patients in China
Q60021974Small cell lung cancer
Q44257767Spanish radiobiological pattern of care in lung cancer: a GOECP/SEOR study
Q35946363The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response
Q36981609The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis
Q33829719Tradeoffs for assuming rigid target motion in Mlc-based real time target tracking radiotherapy: a dosimetric and radiobiological analysis
Q48115777Treatment outcome for locally advanced non-small-cell lung cancer using TomoDirect plan and its characteristics compared to the TomoHelical plan
Q36718717Utilization of PET-CT in target volume delineation for three-dimensional conformal radiotherapy in patients with non-small cell lung cancer and atelectasis

Search more.